Unum Group (UNM) stock analysis
Close on Nov 13, 2026Market cap $12.66BP/E 56.6Yield 2.20%
StockData Score
Prices as of Nov 13, 2026How the score works
Weak7 of 30 checks passed
Unum passes 7 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 1/6
- Growth
- 1/6
- Past performance
- 0/6
- Financial health
- 2/6
- Dividend
- 3/6
What stands out
Low debt
Debt is 35.0% of shareholders' equity, under the 40% we consider low.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 46.8% of total debt.
Guidance raised
Unum raised its Full-year 2026 after-tax adjusted operating income per share growth outlook on Jul 28, 2026.
Covered by free cash flow
Dividends take 19.0% of free cash flow.
What to watch
Return on equity under 15%
Return on equity was 2.2% over the last twelve months and averaged 13.7% over five years; we look for 15% on both.
Earnings shrank over 5 years
Net income shrank 1.4% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew 2.9% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -15.0% a year over the last three fiscal years.
Valuation1/6
P/E above its 5-year median
Unum's P/E of 56.6 is above its own 5-year median of 7.8.
P/E above the industry
Unum's P/E of 56.6 is above the Accident and Health Insurance and Medical median of 21.5.
P/S above the industry
Unum's price-to-sales of 1.01 is above the Accident and Health Insurance and Medical median of 0.81.
P/B below the industry
Unum's price-to-book of 1.17 is below the Accident and Health Insurance and Medical median of 2.29.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing under 10% a year
Revenue grew 2.9% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -15.0% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -73.4% over the last twelve months, against a 5-year average of -1.4% a year.
Growing slower than the industry
Revenue grew -4.2% over the last twelve months; the Accident and Health Insurance and Medical median is 6.8%.
Guidance raised
Unum raised its Full-year 2026 after-tax adjusted operating income per share growth outlook on Jul 28, 2026.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance0/6
Return on equity under 15%
Return on equity was 2.2% over the last twelve months and averaged 13.7% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was 0.4%; for a bank or insurer, 1% or more is considered good.
Return on equity below the industry
Unum's return on equity of 2.2% is below the Accident and Health Insurance and Medical median of 11.9%.
Earnings shrank over 5 years
Net income shrank 1.4% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 1.9% over the last twelve months, against a 5-year average of 9.9%.
Net margin below the industry
Unum's net margin of 1.9% is below the Accident and Health Insurance and Medical median of 2.0%.
Financial health2/6
Low debt
Debt is 35.0% of shareholders' equity, under the 40% we consider low.
Debt rising against equity
Debt to equity rose from 30.8% five years ago to 35.0%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 46.8% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend3/6
Pays a dividend
Unum paid dividends worth 1.8% of the share price over the last twelve months.
Yield below Treasuries
The 1.8% yield is below the 4.7% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Unum yields 1.8%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 9 fiscal years.
Not covered by earnings
Dividends take 127% of net income, leaving little room.
Covered by free cash flow
Dividends take 19.0% of free cash flow.
Fair value
How we estimate itWe don't publish a fair value for Unum. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 7.8
- Accident and Health Insurance and Medical median 21.5
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $189.44M
- Value traded per 1% price move
- $119.43M
Downside
Low risk
- Typical loss in a bad month
- 13.9%
- Volatility (annualized)
- 29%
- Sharpe ratio, 1 year
- -0.05
- Beta to the S&P 500 (5Y)
- 0.62
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +1.5% | +2.9% | -0.1% | +2.0% | |
| Net income | -58.5% | -19.3% | -1.4% | -1.6% | |
| EPS, diluted | -54.9% | -15.0% | +1.9% | +2.0% | |
| Free cash flow | -60.0% | -25.0% | +9.7% | -7.4% | |
| Dividend per share | +12.1% | +11.8% | +9.1% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 10.6% | 7.6% | 6.7% | |
| Return on assets | 1.5% | 1.2% | 1.2% | |
| Debt to equity | 0.33 | 0.31 | 0.34 | |
| Capex to revenue | 0.8% | 0.9% | 1.0% | |
| Diluted shares | 236M | 204M | 173M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Unum generated $6.21B from operations and spent $4.46B on capital expenditure, dividends and share buybacks. 14% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 5.6% | 0.21× | 5.68× | 6.7% |
| FY2024 | 13.8% | 0.21× | 6.07× | 17.3% |
| FY2023 | 10.4% | 0.20× | 6.77× | 14.0% |
| FY2022 | 11.7% | 0.18× | 8.89× | 19.1% |
| FY2021 | 8.2% | 0.17× | 8.33× | 11.6% |
| FY2020 | 6.0% | 0.19× | 6.61× | 7.6% |
| FY2019 | 9.2% | 0.19× | 6.93× | 11.8% |
| FY2018 | 4.5% | 0.18× | 6.92× | 5.8% |
| FY2017 | 8.8% | 0.18× | 6.79× | 10.7% |
| FY2016 | 8.4% | 0.18× | 6.95× | 10.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$738.50M
- Cash generatingOperating cash flow above zero$687.70M
- Return on assets improvedROA up on the prior year2.8% → 1.2%
- Earnings backed by cashOperating cash flow above net income$687.70M vs $738.50M
- Less leverageLong-term debt to assets fell5.6% → 5.9%
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise188M → 173M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.20 → 0.21
See a number that looks wrong?